MARKET

BMRA

BMRA

Biomerica
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.52
-0.10
-1.51%
Opening 15:44 05/28 EDT
OPEN
6.55
PREV CLOSE
6.62
HIGH
6.60
LOW
6.45
VOLUME
115.92K
TURNOVER
--
52 WEEK HIGH
23.39
52 WEEK LOW
2.050
MARKET CAP
73.71M
P/E (TTM)
-24.0236
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BMRA stock price target is 6.25 with a high estimate of 6.25 and a low estimate of 6.25.

EPS

BMRA News

More
Biomerica (NASDAQ:BMRA) Shareholders Have Enjoyed A Whopping 733% Share Price Gain
Simply Wall St. · 05/14 11:40
84 Biggest Movers From Yesterday
Gainers Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) shares climbed 78.6% to close at $2.42 on Thursday after falling 10% on Wednesday.
Benzinga · 05/08 09:34
68 Stocks Moving In Thursday's Mid-Day Session
Gainers Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) shares jumped 114.4% to $2.9050 after falling 10% on Wednesday.
Benzinga · 05/07 16:42
A Look Into Biomerica's Price Over Earnings
Benzinga · 05/07 15:27
PYPL, TEVA among premarket gainers
Seeking Alpha - Article · 05/07 13:19
36 Stocks Moving in Thursday's Pre-Market Session
Gainers Genius Brands International, Inc. (NASDAQ: GNUS) shares rose 150% to $1.20 in pre-market trading after climbing 49% on Wednesday.
Benzinga · 05/07 11:15
UPDATE: Letter From FDA To Biomerica Partner Mount Sinai Lab Shows Authorization Of Emergency Use Of Product
https://www.fda.gov/media/137032/download
Benzinga · 04/16 14:38
Biomerica Q3 Net Loss ~$861K vs Loss ~$679K In Same Qtr. Last Year, Sales $1.177M Down From $1.261M YoY
Biomerica (NASDAQ:BMRA) reported $1.177 million in sales this quarter. This is a 6.66 percent decrease over sales of $1.261 million the same period last year.
Benzinga · 04/15 12:39

Industry

Medical Equipment, Supplies & Distribution
+1.88%
Healthcare Equipment & Supplies
+1.98%

Hot Stocks

Symbol
Price
%Change

About BMRA

Biomerica, Inc. is a biomedical company, which develops, manufactures, and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The medical diagnostic products are sold in two markets: clinical laboratories and point of care. The diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient’s body, stools, or blood, often in extremely small concentrations. Biomerica has developed a diagnostic guided therapy that is designed to allow physicians to identify patient-specific foods, that when removed from the diet, may alleviate or improve an individual's symptoms of Irritable Bowel Syndrome (IBS). This product is called InFoods IBS.
More

Webull offers kinds of Biomerica, Inc. stock information, including NASDAQ:BMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRA stock news, and many more online research tools to help you make informed decisions.